Tang Yue, Wu Jun, Zhang Yuan, Ju Lingpeng, Qu Xiangyang, Jiang Dianming
Department of Traumatic Joint Center, The Third Affiliated Hospital of Chongqing Medical University (General Hospital), No 1 Shuanghu Road, Yubei District, Chongqing 401120, People's Republic of China.
Department of Orthopedics, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatrics, Laboratory of Biomaterials, 136# Zhongshan 2 road, Yuzhong District, Chongqing 400014, People's Republic of China.
R Soc Open Sci. 2021 Jan 13;8(1):201331. doi: 10.1098/rsos.201331. eCollection 2021 Jan.
We prepared the superparamagnetic chitosan nanoparticles (SPCIONPs) to study the application of them as gene vectors using a magnetic transfection system for the targeted treatment of lung metastasis of osteosarcoma. The SPCIONPs were characterized by transmission electron microscopy, Fourier transform infrared spectrometry, superconducting quantum interference device and atomic force microscopy. Their biosafety was determined by cell counting kit-8 (CCK8) and live-dead staining assays. The transfection was detected by laser confocal microscopy. SPCIONPs, which can bind closely to plasmids and protect them from DNA enzyme degradation, were prepared with an average particle size of approximately 22 nm and zeta potential of 11.3 mV. The results of the CCK8 and live-dead staining assays showed that superparamagnetic chitosan nanoparticles loaded with insulin-like growth factor-binding protein 5 (SPCIONPs/pIGFBP) induced no significant cytotoxicity compared to the control group. The result of transfection suggested that pIGFBP emitted a greater amount of red fluorescence in the SPCIONPs/pIGFBP group than that in the chitosan-loaded IGFBP (CS/pIGFBP) group. In conclusion, the prepared SPCIONPs had good biosafety and could be effectively used to transfer pIGFBP into 143B cells, and they thus have good application prospects for the treatment of lung metastasis of osteosarcoma.
我们制备了超顺磁性壳聚糖纳米颗粒(SPCIONPs),以研究其作为基因载体在利用磁转染系统靶向治疗骨肉瘤肺转移中的应用。通过透射电子显微镜、傅里叶变换红外光谱、超导量子干涉装置和原子力显微镜对SPCIONPs进行了表征。通过细胞计数试剂盒-8(CCK8)和活死染色试验确定其生物安全性。通过激光共聚焦显微镜检测转染情况。制备得到的SPCIONPs能与质粒紧密结合并保护其免受DNA酶降解,平均粒径约为22 nm,zeta电位为11.3 mV。CCK8和活死染色试验结果表明,与对照组相比,负载胰岛素样生长因子结合蛋白5的超顺磁性壳聚糖纳米颗粒(SPCIONPs/pIGFBP)未诱导明显的细胞毒性。转染结果表明,pIGFBP在SPCIONPs/pIGFBP组中发出的红色荧光量比负载壳聚糖的IGFBP(CS/pIGFBP)组更多。总之,制备的SPCIONPs具有良好的生物安全性,可有效地将pIGFBP转入143B细胞,因此在骨肉瘤肺转移治疗中具有良好的应用前景。